Skip to content Skip to navigation

Proteomic Markers

AutoGenomics
AutoGenomics
2251 Rutherford Road Carlsbad, CA 92008 USA

AutoGenomics has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics.